Regulatory PathRegulatory requirements compared

Active substances

Amiloride + Hydrochlorothiazide

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade nameStrengthForm · routePackPublic priceTypeCompanyStatus
AMURETIC 5MG/50MG TAB50,5 mg,mgTablet · Oral use20 BlisterSAR 8.75Generic · PrescriptionDAR ALDAWAValid
MODURETIC 5-50MG TABLETS50,5 mg,mgTablet · Oral use30 BlisterSAR 17.60Generic · PrescriptionAlgorithm SALSuspended
APO-AMILZIDE5, 50 mgTablet · Oral use30 BlisterSAR 15.80Generic · PrescriptionAPOTEXWithdrawn by MAH · Not Marketed
Indications — CHI Daman Drug Formulary

CONGESTIVE HEART FAILURE; HYPERTENSION; PULMONARY ARTERIAL HYPERTENSION

US FDA United States — FDA approvals (Drugs@FDA)

ProductStrengthForm · routeApplicantStatusFirst approved
AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDEEQ 5MG ANHYDROUS;50MGtablet · oralBARRPrescription10 May 1988
AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDEEQ 5MG ANHYDROUS;50MGtablet · oralRISINGPrescription31 Oct 1991
MODURETIC 5-50EQ 5MG ANHYDROUS;50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**tablet · oralMERCKDiscontinued5 Oct 1981
HYDRO-RIDEEQ 5MG ANHYDROUS;50MGtablet · oralPAR PHARMDiscontinued6 Aug 1986
AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDEEQ 5MG ANHYDROUS;50MGtablet · oralTEVADiscontinued15 Jul 1987
AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDEEQ 5MG ANHYDROUS;50MGtablet · oralWATSON LABSDiscontinued19 Jul 1991
AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDEEQ 5MG ANHYDROUS;50MGtablet · oralCHARTWELL RXDiscontinued27 Nov 1991

Canada Canada — marketed products (Health Canada)

BrandDINStrengthForm · routeCompany
AA-AMILZIDE007844005 MG; 50 MGTABLET · ORALAA PHARMA INC

Prices — United States and England

SourceProduct as listedPriceUnit / packDate
US NADACAMILORIDE HCL-HYDROCHLOROTHIAZIDE 5-50 MG TAB$0.44985per EA23 Sep 2026
NHS Drug TariffCo-amilozide 2.5mg/25mg tablets£92.1728 tablet1 Oct 2026
NHS Drug TariffCo-amilozide 5mg/50mg tablets£28.3528 tablet1 Oct 2026

NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.

Components

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.